EPM2A anticorps (AA 243-331)
-
- Antigène Voir toutes EPM2A Anticorps
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
-
Épitope
- AA 243-331
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp EPM2A est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Purification
- Protein G purified
- Immunogène
-
Recombinant human EPM2A (243-331aa) purified from E. coli. NCBI Accession NO: NP_005661.
Type of Immunogen: Recombinant protein - Clone
- K2A3
- Isotype
- IgG1
- Top Product
- Discover our top product EPM2A Anticorps primaire
-
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 101-199) antibody
EPM2A Reactivité: Humain WB, ELISA Hôte: Souris Monoclonal 6C6 unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (C-Term) antibodyEPM2A Reactivité: Humain WB, IF, IHC (p), ICC Hôte: Lapin Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 1-331), (Isoform 9) antibodyEPM2A Reactivité: Humain WB, ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 244-331) antibodyEPM2A Reactivité: Humain ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) antibodyEPM2A Reactivité: Humain, Rat, Souris ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 1-331) antibodyEPM2A Reactivité: Humain WB, IP Hôte: Lapin Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 80-130) antibodyEPM2A Reactivité: Humain, Boeuf (Vache) WB, IHC, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 101-199) antibodyEPM2A Reactivité: Humain WB, ELISA Hôte: Souris Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 1-331) antibodyEPM2A Reactivité: Humain WB Hôte: Souris Polyclonal unconjugated
anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 244-331) antibodyEPM2A Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
-
Approved: ELISA, WB (1:1000 - 1:2000)
Usage: The antibody has been tested by ELISA and Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Recommended dilution range for Western blot analysis is 1:1000-1:2000.
Not recommended for: IHC-P - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.4, 0.1 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- avoid freeze thaw cycles.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
- Antigène
- EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
- Autre désignation
- EPM2A / Laforin (EPM2A Produits)
- Synonymes
- anticorps TG-B, anticorps Tg(TcraK,TcrbK)TG-BFlv, anticorps EPM2, anticorps MELF, anticorps laforin, anticorps EPM2A, laforin glucan phosphatase, anticorps epilepsy, progressive myoclonic epilepsy, type 2 gene alpha, anticorps EPM2A, anticorps Epm2a
- Sujet
-
Name/Gene ID: EPM2A
Subfamily: Laforin
Family: Protein Phosphatase
Synonyms: EPM2A, EPM2, LAFPTPase, LDE, Lafora PTPase, MELF, Laforin, LD - ID gène
- 7957
- NCBI Accession
- NP_005661
- UniProt
- O95278
- Pathways
- Cellular Glucan Metabolic Process
-
